Rapidly progressive glomerulonephritis surgery: Difference between revisions
Esther Lee (talk | contribs) (Created page with "__NOTOC__ {{Rapidly progressive glomerulonephritis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing....") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Rapidly progressive glomerulonephritis}} | {{Rapidly progressive glomerulonephritis}} | ||
{{CMG}}; {{AE}} {{AEL}} | |||
==Overview== | |||
Surgery is not the first-line treatment option for patients with rapidly progressive glomerulonephritis. [[Renal transplantation]] is usually reserved for patients who present with undetectable circulating [[Anti-glomerular basement membrane antibody|anti-glomerular basement antibodie]]<nowiki/>s in serum for 12 months and at least 6 months after stopping the use of [[cytotoxic]] agents. | |||
==Surgery== | |||
*Surgical intervention in the form of [[renal transplantation]] is indicated in patients with [[end-stage renal disease]]. | |||
*[[Renal transplantation]] may be performed when [[Anti-glomerular basement membrane antibody|anti-glomerular basement membranes]] are undetectable for 6 months with no signs of [[pulmonary]] involvement.<ref name="pmid25553369">{{cite journal| author=Menn-Josephy H, Beck LH| title=Recurrent glomerular disease in the kidney allograft. | journal=Front Biosci (Elite Ed) | year= 2015 | volume= 7 | issue= | pages= 135-48 | pmid=25553369 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25553369 }} </ref><ref name="pmid25028634">{{cite journal| author=| title=Notice. | journal=Kidney Int Suppl (2011) | year= 2012 | volume= 2 | issue= 2 | pages= 139 | pmid=25028634 | doi=10.1038/kisup.2012.9 | pmc=4089568 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25028634 }} </ref><ref name="pmid20924413">{{cite journal| author=Chen M, Kallenberg CG| title=ANCA-associated vasculitides--advances in pathogenesis and treatment. | journal=Nat Rev Rheumatol | year= 2010 | volume= 6 | issue= 11 | pages= 653-64 | pmid=20924413 | doi=10.1038/nrrheum.2010.158 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20924413 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Autoimmune diseases]] | |||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:Rheumatology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Needs content]] | |||
[[Category:Disease]] | |||
Latest revision as of 18:20, 23 May 2018
|
Rapidly progressive glomerulonephritis Microchapters |
|
Differentiating Rapidly progressive glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Rapidly progressive glomerulonephritis surgery On the Web |
|
American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis surgery |
|
Directions to Hospitals Treating Rapidly progressive glomerulonephritis |
|
Risk calculators and risk factors for Rapidly progressive glomerulonephritis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Surgery is not the first-line treatment option for patients with rapidly progressive glomerulonephritis. Renal transplantation is usually reserved for patients who present with undetectable circulating anti-glomerular basement antibodies in serum for 12 months and at least 6 months after stopping the use of cytotoxic agents.
Surgery
- Surgical intervention in the form of renal transplantation is indicated in patients with end-stage renal disease.
- Renal transplantation may be performed when anti-glomerular basement membranes are undetectable for 6 months with no signs of pulmonary involvement.[1][2][3]
References
- ↑ Menn-Josephy H, Beck LH (2015). "Recurrent glomerular disease in the kidney allograft". Front Biosci (Elite Ed). 7: 135–48. PMID 25553369.
- ↑ "Notice". Kidney Int Suppl (2011). 2 (2): 139. 2012. doi:10.1038/kisup.2012.9. PMC 4089568. PMID 25028634.
- ↑ Chen M, Kallenberg CG (2010). "ANCA-associated vasculitides--advances in pathogenesis and treatment". Nat Rev Rheumatol. 6 (11): 653–64. doi:10.1038/nrrheum.2010.158. PMID 20924413.